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In this report, we provide a detailed characterization of the human cytomegalovirus (HCMV) UL94 gene
product. Northern (RNA) blot analysis of infected cell RNA demonstrated that UL94 message was found only
at late times of infection and was not synthesized in the presence of the viral DNA replication inhibitor
ganciclovir. Expression of the UL94 open reading frame in vitro and in vivo yielded a protein with the predicted
molecular mass of 36 kDa. A monoclonal antibody raised to a UL94-specific peptide reacted specifically with
a 36-kDa protein in HCMV-infected fibroblasts. This protein was found only at late times of infection and was
also present in purified HCMV virions. Fractionation of purified virions and HCMV-infected cells revealed an
association of UL94 immunoreactivity with the capsid/tegument and nuclear fractions, respectively. The
evolutionary conservation of UL94 protein sequence and an analysis of potential functional regions of the
protein are discussed.
Human cytomegalovirus (HCMV) is the most widely studied
member of the beta family of herpesviruses and is ubiquitous
within the human population. It is associated with myriad clin-
ical manifestations resulting from primary, persistent, or reac-
tivated infection, including retinitis, coronary restenosis, and
birth defects (2, 19, 28, 35, 36, 41). Because of its restrictive
host range, studies of the HCMV replicative cycle have been
limited primarily to tissue culture or in vitro work; however,
much insight into the functions of important viral gene prod-
ucts and their roles during infection has been gained within
these systems (19, 28, 36).
Analysis of the structure, function, and regulation of HCMV
genes has been facilitated by the publication of the entire
genomic sequence for laboratory strain AD169 (8). Sequence
analysis of the genome has revealed a number of core open
reading frames (ORFs) which are conserved with other her-
pesviruses as well as numerous HCMV-specific genes (7, 8).
Some of this latter group have been demonstrated to bear
homology to cellular proteins of known function, including
G-protein-coupled receptors (10, 38), the T-cell receptor g
subunit (8), and the major histocompatibility class I antigen
(6). The functions of many of the estimated 200 viral gene
products, however, remain obscure.
In an effort to add to our understanding of the function and
regulation of expression of uncharacterized viral gene prod-
ucts, our laboratory has recently provided initial characteriza-
tions of a number of novel viral proteins, including the UL84
and US18-20 gene products (15, 16). Analysis of these proteins
indicated that UL84 was an HCMV nuclear compartment-
associated early protein (16), while the US18-20 proteins were
multiply hydrophobic membrane-spanning proteins (15). Sub-
sequently, the UL84 gene product was shown to be essential
for viral DNA replication (30) and to physically interact with
the viral immediate-early protein IE2-86 kDa (34).
With this in mind, we recently characterized a family of
novel overlapping transcripts which code for HCMV ORFs
UL93 to UL99 (39). These ORFs are located within a region of
the HCMV genome which is conserved in all other human
herpesviruses (7, 8, 9, 12, 31, 33). Very little information is
currently available concerning the function and/or regulation
of expression of these viral gene products; however, at least
two of the gene products are thought to play a role in viral
DNA replication: the protein product of the UL97 ORF was
recently shown to be involved in the phosphorylation of gan-
ciclovir during a productive HCMV infection (22, 37), and the
UL98 ORF is thought to encode a DNase, as judged from its
homology with a positionally conserved ORF in herpes simplex
virus (HSV) (7, 8, 12). In addition, the UL99 gene product
(pp28) is an extensively studied virion phosphoprotein which is
expressed as a true late gene (20, 21, 24, 25, 29). Kinetic
analysis of the transcripts specific for ORFs UL93 to UL98
suggested that ORFs UL95, UL96, and UL97 (ganciclovir ki-
nase) and UL98 (DNase) were likely to be early or early-late
gene products, while ORF UL94 (and possibly UL93) was
likely to be a late gene (39). This kinetic analysis provides an
estimation of the phase during the replicative cycle in which
these gene products are needed by the virus and thus provides
initial clues as to possible functions of these uncharacterized
viral proteins. Follow-up studies for the UL98 transcription
unit have subsequently confirmed and extended these predic-
tions for the UL98 protein (1).
In an effort to extend the observations made on the basis of
transcription data cited above, we have begun characterization
of additional novel gene products associated with the UL93 to
UL98 gene region. In this report, we provided an initial char-
acterization of the UL94 protein. We demonstrate that UL94
is regulated as a true late gene and that UL94 protein is found
in HCMV virions and in the nuclei of infected cells. Addition-
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ally, we provide an analysis of the UL94 protein sequence with
respect to potential functional regions which are conserved in
the UL94 homologs of other herpesviruses.
MATERIALS AND METHODS
Cells and virus. Human embryonic lung cells (HELs) and HCMV (Towne
strain) were maintained and propagated as previously described (18, 39). Human
293-T cells (a gift of Colin Duckett) were maintained in Dulbecco modified
Eagle medium (DMEM) supplemented with 10% fetal calf serum (13).
DNA cloning and plasmids. UL94 coding sequences were cloned by PCR
amplification from 50 ng of EcoRI-digested HCMV (Towne) genomic DNA,
using 20 pmol of the following primers: 59-GCATGCATGGATCCATGGCTT
GGCGCAGCGGGCTTTGCGAG-39 and 59-GCATGCATGAATCCGTGCAC
TAGGTTCTTAAGCACCG-39. A BamHI site was incorporated into the 59
primer (underlined) to facilitate cloning. Amplification was carried out by using
Vent DNA polymerase (New England Biolabs) and a Perkin-Elmer Cetus DNA
thermocycler. The ends of the amplified product were flushed with T4 polynu-
cleotide kinase (Boehringer Mannheim) and Klenow DNA polymerase (Pro-
mega); the product was digested with BamHI and cloned into BamHI-SmaI-
digested pBS(1) (Stratagene). The resultant plasmid (pBSUL94) was used in in
vitro transcription-translation analysis (described below).
For expression in vivo, UL94 coding sequences were PCR amplified from
pBSUL94 with the following primers: 59-GCATGCATGGTACCATGGCTTG
GCGCAGCGGGCTTTGCGAG-39 and 59-GCATGCATGGATCCTTACACC
ACCACCACCACCACGTGCACTAGGTTCTTAAGCACCG-39. KpnI and
BamHI sites (underlined) were incorporated into the 59 and 39 primers, respec-
tively, to facilitate cloning. A six-histidine tag (also underlined) was incorporated
into the 39 primer prior to the UL94 stop codon to facilitate purification of the
expressed protein. The amplified product was digested with BamHI and KpnI
and cloned into BamHI-KpnI-digested pCEP4 (Invitrogen). The resultant plas-
mid (pCEPUL94) was used for in vivo expression of UL94-His protein driven by
the HCMV major immediate-early enhancer located within pCEP4.
Expression of UL94 coding sequences.For expression in vitro, plasmid pBSUL94
was linearized with EcoRI and in vitro transcribed with T3 RNA polymerase
(Promega) by using the Promega in vitro transcription kit. In vitro transcripts
were translated by using rabbit reticulocyte lysate (Promega) and labeled with
[35S]methionine (1,280 Ci/mmol; Amersham). In vitro-translated proteins (1 ml)
were run on sodium dodecyl sulfate (SDS)-polyacrylamide gels; the gels were
subsequently incubated in 1 M sodium salicylate (Boehringer Mannheim) for 30
min, vacuum dried for 30 min, and exposed to film overnight at 2708C.
For expression in vivo, one 100-mm-diameter dish of human 293-T cells was
transfected with either 5, 10, or 15 mg of pCEPUL94, control plasmid pCEP4
(empty vector), or pCEPgB (HCMV glycoprotein B gene; a gift from Jay Nelson)
via calcium phosphate precipitation (3). After an overnight transfection, the
precipitate was washed away with DMEM and the cells were incubated with
DMEM supplemented with 10% fetal calf serum. After 6 h, the medium was
changed to DMEM supplemented with 10% fetal calf serum and 200 mg of
hygromycin B (Boehringer Mannheim) per ml. After 3 days, hygromycin-resis-
tant cells were pooled and passaged into 100-mm-diameter dishes, using the
same medium. After two passages, cells were expanded to T150 flasks and
analyzed for UL94 RNA and protein expression.
RNA isolation and Northern (RNA) blot analysis. Whole cell RNA was iso-
lated from 293-T cell lines and mock- or HCMV (Towne)-infected HELs by the
guanidinium isothiocyanate-cesium chloride method (3). Infected cells were har-
vested at 0, 4, 24, 48, 72, and 144 h postinfection (hpi) as well as at 72 hpi in the
presence of 10 mM 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG). North-
ern blots were prepared and probed with end-labeled UL94-specific oligonucle-
otide UL94-1 as described previously (39).
Cell and virion fractionation.HCMV-infected HELs and 293-T cell lines were
separated into crude nuclear and membrane/cytoplasmic fractions by lysis of cells
with 0.1% Nonidet P-40 in hypotonic buffer. The intact nuclei were pelleted at
1,500 rpm and washed with phosphate-buffered saline (PBS), and the membrane/
cytoplasmic fraction was clarified by centrifugation at 14,000 rpm. Fractions were
probed by Western blotting (immunoblotting) with antibodies to cellular mem-
brane/cytoplasmic and nuclear fraction-specific proteins Ras-GAP and p53 (both
from Santa Cruz Biotechnology), respectively, to determine purity of fractions.
HCMV (Towne) virions were separated into envelope and capsid/tegument
fractions by addition of 1% Nonidet P-40 to the virions and incubation on ice for
30 min. Samples were subsequently layered onto 30% sucrose cushions and
centrifuged at 45,000 rpm for 90 min at 48C. The envelope fraction was collected
from the top of the sample. The capsid/tegument pellet was resuspended in 13
PBS. To assess the purity of the fractions, Western blots of both fractions were
probed with antisera to HCMV IE1-72 kDa (a capsid/tegument-associated pro-
tein) and HCMV glycoprotein B (an envelope-specific protein).
Western blot analysis.Whole cell protein lysates from 293-T cell lines as well
as mock- and HCMV-infected HELs were prepared by lysing cells in equal
volumes of 13 PBS and 23 SDS-polyacrylamide gel electrophoresis (PAGE)
sample buffer (1.52 mg of Tris base per ml, 20% glycerol, 2 mg of SDS per ml,
2% b-mercaptoethanol, 1% bromophenol blue); 2% b-mercaptoethanol in the
sample buffer was substituted with 150 mM dithiothreitol (DTT; Boehringer
Mannheim) or 150 mM iodoacetimide (Sigma) for some experiments. Purified
HCMV virions were prepared as described previously (18). Proteins were sep-
arated by electrophoresis on 4% stacking–12% separating SDS-containing poly-
acrylamide gels, using minigel rigs (Bio-Rad). Gels were subsequently trans-
ferred overnight to Immobilon-P membranes (Millipore) and probed with the
appropriate primary antisera followed by secondary peroxidase-linked antibod-
ies. Blots were developed by using an enhanced chemiluminescence detection
system (Amersham).
Monoclonal antibody production. UL94 monoclonal antibodies were gener-
ated by using standard techniques (3). Primary immunization was carried out
with a branched peptide corresponding to UL94 amino acid residues 26 to 40
(KLVGKSRKHREYRAV) (purchased from Research Genetics). Hybridoma
supernatants were screened for UL94 peptide reactivity by enzyme-linked im-
munosorbent assay (ELISA); ELISA-positive samples were tested for UL94
reactivity by Western blotting with purified UL94-His as well as HCMV-infected
cell extracts. For antibody competition experiments, monoclonal antibodies were
preincubated with 0 to 100 mg of either UL94 or nonspecific protein kinase C
(PKC) peptide per ml prior to use in Western blot analysis.
Affinity purification of histidine-tagged UL94. UL94-His expressed in perma-
nently transfected 293-T cells was purified by incubating three T150 flasks of cells
lysed in IMAC-5 (20 mM Tris-HCl [pH 7.9], 0.5 M NaCl, 10% glycerol, 1 mM
phenylmethylsulfonyl fluoride, 5 mM imidazole)–1% Nonidet P-40 with 20 to 50
ml of nickel-agarose beads (Novagen) in a total volume of 10 ml. Following
incubation, the beads were washed five times with 1 ml of IMAC-5, and proteins
were eluted stepwise by incubating beads with IMAC-5 supplemented with 24.5
to 200 mM imidazole. Elutions were subjected to SDS-PAGE followed by either
Coomassie blue staining or Western blot analysis.
RESULTS
Kinetics of UL94 RNA expression. We previously reported
that coding sequences for HCMV ORFs UL93 to UL99 were
present on a series of overlapping transcripts found in produc-
tively infected cells (39). UL94-associated transcripts were
demonstrated to initiate 335 nucleotides (nt) upstream of the
UL94 initiation codon and to utilize two distinct polyadenyla-
tion sites. Use of the first site, located 512 nt downstream of
the UL94 termination codon, results in a 2.0-kb UL94-specific
message; use of the second polyadenylation site, located 176 nt
downstream of the UL99 termination codon, results in a 9.1-kb
message which also hybridizes to probes specific for ORFs
UL95 to UL99 (Fig. 1a). This larger message was shown to be
expressed only at late times of infection and to be sensitive to
inhibitors of viral DNA replication. The kinetics of the smaller
(2.0-kb) message, however, were not shown in the previous
study (39). To determine the pattern of expression of the
2.0-kb message, we prepared RNA from mock- and HCMV
(Towne)-infected HELs and performed Northern blot analysis
using an end-labeled UL94-specific oligonucleotide probe. The
results of this experiment indicate that the 2.0-kb UL94-spe-
cific transcripts are detected only at late times of infection (Fig.
FIG. 1. Expression of UL94 mRNA during HCMV infection of HELs. (A)
Schematic of the UL94 to UL99 gene region showing the structures of the UL94
9.1- and 2.0-kb RNAs as determined previously (58). Downward arrows indicate
consensus polyadenylation signals. (B) Northern blot analysis of the UL94 2.0-kb
mRNA from HCMV-infected HELs probed with UL94-specific oligonucleotide
UL94-1. RNA samples: mock infected (lane 1), 0 hpi (lane 2), 4 hpi (lane 3), 24
hpi (lane 4), 48 hpi (lane 5), 72 hpi (lane 6), 72 hpi plus DHPG (lane 7), and 144
hpi (lane 8).
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1B, lanes 5, 6, and 8). In addition, no 2.0-kb transcripts are
detected at 72 hpi in the presence of ganciclovir (lane 7). These
results suggest that the 2.0-kb UL94-specific transcripts are
expressed with true late kinetics.
Exogenous expression of UL94 coding sequences. To more
closely examine the viral gene product(s) associated with ORF
UL94, the predicted coding sequences for UL94 were sub-
cloned from HCMV (Towne) genomic DNA by PCR amplifi-
cation using primers spanning sequences between the pre-
dicted N-terminal and C-terminal ends of the UL94 reading
frame; the putative stop codon for UL94 was also included in
the amplified product (see Materials and Methods for primer
sequences). Using these primers, we were able to specifically
amplify a double-stranded DNA product approximately 1 kb in
size from total HCMV genomic DNA (Fig. 2A). The size of
this product was consistent with the predicted size of 1,038 bp
for the UL94 reading frame (7, 8). To determine the coding
capacity of the amplified product, we subcloned the PCR frag-
ment and expressed the cloned HCMV sequences by in vitro
transcription-translation. Analysis of the proteins produced in
this reaction revealed that a 36-kDa protein was specifically
produced in the UL94 in vitro translation reaction (Fig. 2B).
This size was in agreement with the predicted molecular mass
of 36 kDa for the 346-amino-acid UL94 reading frame (7, 8).
DNA sequence analysis of the termini of the DNA insert used
in the in vitro transcription-translation reaction confirmed that
the expected UL94 coding sequences had been successfully
subcloned (40).
We also examined the expression of UL94 coding sequences
in vivo by generating a stably transfected human kidney-de-
rived 293-T cell line expressing UL94 protein from the HCMV
major immediate-early enhancer/promoter. To facilitate anal-
ysis and affinity purification of eukaryotically expressed UL94
protein, a six-histidine-codon tag was incorporated onto the 39
end of the subcloned UL94 product (prior to the stop codon)
as described in Materials and Methods. To examine UL94-
specific RNA expression, whole cell RNA was isolated from
the UL94 cell lines, as well as control cell lines containing
either no expression vector, empty expression vector, or
HCMV glycoprotein B expression vector, and analyzed by
Northern blot hybridization to a UL94 oligonucleotide probe.
The results of this experiment indicated that the UL94 cell
lines expressed a 1.3-kb transcript which hybridized with the
UL94 probe (Fig. 3A, lanes 4 to 7); none of the control cell
lines contained UL94-cross-reactive RNA (lanes 1 to 3). To
examine UL94 protein expression, UL94-His protein was af-
finity purified on nickel-agarose beads. Results of this experi-
ment indicated that the UL94 cell lines specifically contained
an approximately 36-kDa protein which was purified on the
nickel-agarose beads (Fig. 3B, lanes 3 and 5); this protein was
not present in cell lysates from control cell lines (lanes 2 and
4). The molecular weight of the nickel-agarose affinity-purified
protein corresponded with the size of in vitro-expressed UL94
as well as the expected molecular weight of UL94 protein,
indicating that it was likely that the UL94 cell lines expressed
histidine-tagged UL94.
To facilitate further analysis of the UL94 gene product, we
sought to generate an antiserum specific for UL94 protein.
Mice were immunized with a peptide corresponding to amino
acids 26 to 40 of the UL94 reading frame (see Materials and
Methods for peptide sequences). The presence of codons cor-
responding to this peptide sequence in our subcloned UL94
DNA fragment was confirmed by DNA sequence analysis of
the corresponding region of the pBSUL94 insert (40). One
monoclonal antibody (designated UL94-9) that was generated
reacted strongly to the UL94 peptide by ELISA (40). To ex-
amine the specificity of monoclonal antibody UL94-9, we ini-
tially tested its ability to recognize UL94 protein in Western
blots of imidazole elutions from nickel-agarose affinity-purified
UL94-His cell lines. The results indicated that UL94-9 de-
tected a 36-kDa protein in the imidazole elutions containing
FIG. 2. Expression of UL94 coding sequences in vitro. (A) PCR amplifica-
tion of the UL94 ORF from EcoRI-cut HCMV (Towne) genomic DNA (lane 2)
and HindIII-digested l markers (lane 1). (B) In vitro translation of UL94 PCR
product cloned into vector pBS(1) showing the 36-kDa UL94 protein (lane 2)
and the control luciferase translation (lane 1).
FIG. 3. Expression and purification of UL94 as a histidine-tagged protein from stably transfected human 293-T cells. (A) Northern blot of whole cell RNA isolated
from 293-T cells (lane 1) and 293-T cells stably transfected with pCEP4 (lane 2), pCEBgB (lane 3), and four different cell lines stably transfected with pCEPUL94: 94.5
(lane 4), 94.10 (lane 5), 94.15A (lane 6), and 94.15B (lane 7). The 1.3-kb size of the UL94 RNA is indicated. (B) Coomassie-stained SDS-polyacrylamide gel of UL94-His
purified by nickel-agarose affinity chromatography from cell lines 94.5 (lane 3) and 94.15B (lane 5) as well as control purifications from untransfected 293-T cells (lane
2) and pCEP4-transfected cells (lane 4). Sizes (in kilodaltons) of protein molecular weight markers (lane 1) are indicated at the left. (C) Western blot of imidazole
elutions of nickel-agarose affinity-purified UL94-His from cell line 94.15B. The imidazole concentrations are 24.5 mM (lane 1), 30.5 mM (lane 2), 102.5 mM (lane 3),
141.5 mM (lane 4), 180.5 mM (lane 5), and 200 mM (lane 6).
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UL94-His protein (Fig. 3C, lanes 2 to 4). Additional assays for
UL94-9 antibody specificity are detailed below.
Western blot analysis of UL94 protein in HCMV-infected
fibroblasts. To examine expression of UL94 protein during a
productive infection by HCMV, protein extracts were prepared
from HCMV-infected HELs at 5, 24, 48, and 72 hpi, as well as
from mock-infected HELs, and examined by Western blotting
with antibody UL94-9. The results of this experiment indicated
that the UL94-9 antiserum reacted specifically with a 36-kDa
protein (band 1) found exclusively in infected cells (Fig. 4,
lanes 2 to 5); no UL94 reactivity was seen in mock-infected
cells (lane 1). The 36-kDa protein could be detected only at
late times of infection and was maximal at 72 hpi (lane 5). This
result is consistent with the Northern blot data (Fig. 1), which
demonstrated that UL94-specific transcripts were detected
only at late times of infection. In addition to the 36-kDa pro-
tein, a 72-kDa species (band 2) was also detected at 72 hpi
(lane 5). The presence of this band in Western blots appeared
to be primarily dependent on the reducing conditions used to
prepare extracts for SDS-PAGE (lanes 6 to 9). When extracts
from 72-hpi-infected cells were prepared with no reducing
agent in the SDS-PAGE sample buffer (lane 6), or when sam-
ples were prepared with 150 mM iodoacetimide (lane 7) or 2%
b-mercaptoethanol (lane 8), the UL94-reactive species mi-
grated predominantly at a molecular mass of 72 kDa; however,
in the presence of 150 mMDTT (lane 9), a noticeable decrease
in the 72-kb species (band 2) was accompanied by an increase
in the 36-kDa species (band 1). Variable amounts of the 72-kb
band persisted in cell extracts following treatment with DTT
(lanes 5 and 9). In addition, several larger-molecular-weight
species were observed when no reducing agent was added to
the sample buffer or in the presence of 2% b-mercaptoethanol
(lanes 6 and 8, bracket 3). We could also detect the 72-kDa
species exclusively when UL94 from the UL94 cell lines (lane
10) or in infected cell extracts at 48 hpi (lane 11) was analyzed
by Western blot under less than ideal reducing conditions,
indicating that no novel viral gene product is required to detect
the 72-kDa species. Taken together, these results suggest that
the appearance of the 72-kDa species is dependent on the
reducing conditions of sample preparation and that it may, in
fact, represent a disulfide-linked dimer of 36-kDa UL94 mono-
mers. This conclusion is supported by the significant number of
cysteine residues present in the primary amino acid sequence
of UL94 which are conserved in the UL94 homologs of other
herpesviruses (see Fig. 7). The possible significance of the
72-kDa species is addressed in Discussion.
Virion association of UL94 protein. Predominantly late pro-
teins from herpesviruses are often virion structural compo-
nents; we therefore looked for UL94 protein in HCMV parti-
cles. Purified, enveloped HCMV virions were probed in
Western blots with the UL94-9 antiserum as shown in Fig. 5.
The results of this experiment indicate that UL94 protein is
associated with HCMV particles (Fig. 5, lanes 1 and 2). Pro-
teins of identical size were detected in virions from both
Towne (lane 1) and AD169 (lane 2) strains, indicating that the
peptide sequence used to generate antibody UL94-9 is con-
served in the two strains. We also examined the specificity of
the antibody for the 36- and 72-kDa UL94 bands in virions by
preincubating the antiserum with increasing amounts of UL94
peptide, or an unrelated peptide, and probing Western blots of
HCMV (Towne) virion proteins (lanes 3 to 6). The results of
this experiment indicated that the UL94 peptide specifically
competed for both the 36- and 72-kDa bands (lanes 4 and 5),
while a peptide to protein kinase C had no effect on UL94
immunoreactivity (lane 6). Thus, both protein species are spe-
cific for UL94 protein, and the antibody specifically recognizes
a UL94-specific peptide sequence.
HCMV virion envelope proteins are often found in disul-
fide-linked complexes (14). Since UL94 protein had an appar-
ent propensity to form disulfide-linked dimers in vitro, we
suspected that UL94 protein would be associated with the
HCMV virion envelope. To test this hypothesis, whole HCMV
virions were separated into envelope and capsid/tegument
fractions and analyzed by Western blot analysis (Fig. 5, lanes 7
to 9). Analyses with control antisera indicated that the capsid/
tegument fraction contained only minor levels of envelope
proteins and that the envelope fraction contained exclusively
envelope proteins (lanes 10 and 11). When these fractions
were probed with a UL94 antiserum, we detected UL94 im-
munoreactivity exclusively in the capsid/tegument fraction
(lane 9), indicating that, surprisingly, UL94 protein was not
associated with the viral envelope. This result suggests that
UL94 protein is a structural component of the capsid or teg-
ument. Since the major structural proteins of the viral capsid
have been documented, UL94 is more likely to be associated
with the tegument.
Subcellular localization of UL94 protein. To examine the
localization of UL94 protein in infected cells, 72-hpi-infected
cells were fractionated into nuclear and cytoplasmic/mem-
brane fractions by Nonidet P-40 lysis and probed for UL94
FIG. 4. Western blot analysis of UL94 protein from infected cells. Lanes: 1 to
5, infection time course Western blot analysis using protein extracts prepared
with 150 mM DTT from mock-infected HELs (lane 1) as well as infected cells at
5 (lane 2), 24 (lane 3), 48 (lane 4), and 72 hpi (lane 5) probed with monoclonal
antibody UL94-9; 6 to 9, 72-hpi cell lysates prepared with no reducing agent (lane
6), 150 mM iodoacetimide (IAA; lane 7), 2% b-mercaptoethanol (BME; lane 8),
or 150 mM DTT (lane 9) and analyzed by Western blotting with antibody
UL94-9; 10 and 11, Western blot analysis of 48-hpi cell extract (lane 10) and
affinity-purified UL94-His (lane 11) prepared with 2% b-mercaptoethanol and
probed with antibody UL94-9. The 36-kDa UL94 protein is indicated by arrow 1;
the 72-kDa form and larger forms are indicated by arrow 2 and bracket 3,
respectively.
FIG. 5. Western blot analysis of UL94 protein from purified HCMV virions.
Lanes: 1 and 2, Western blot of Towne (lane 1) and AD169 (lane 2) virions; 3 to
6, peptide competitions of the UL94-9 antiserum preincubated with 0 (lane 3), 10
(lane 4), and 100 (lane 5) mg of UL94 peptide per ml or 10 mg of PKC peptide
per ml (lane 6) and used to probe Western blots of HCMV (Towne) virions; 7 to
9, Western blot of HCMV (Towne) whole virions (lane 7), virion envelope (lane
8), and virion capsid/tegument (lane 9) fractions (both the 36- and 72-kDa forms
of UL94 are indicated); 10 and 11, Western blot controls of virion envelope (lane
10) and capsid/tegument (lane 11) fractions probed with antisera specific for
HCMV glycoprotein B (gB) and IE1-72 kDa proteins.
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reactivity in Western blots. The results (Fig. 6, lanes 1 and 2)
demonstrate that UL94 protein is localized to the nuclear
fraction of the infected cell, since UL94 immunoreactivity was
seen only in the nuclear fraction. Control experiments using
either Ras-specific GTPase-activating protein (a membrane
associated protein) or p53 (a nuclear protein in HCMV-in-
fected cells and some transformed cell lines) indicated that the
fractions were highly enriched (Fig. 6, bottom two panels).
Since no UL94 reactivity was seen in the membrane/cytoplas-
mic fraction, no additional fractionation of infected cells was
carried out. We also fractionated UL94-expressing cell lines to
determine whether a similar localization would be observed.
The results of this experiment (Fig. 6, lanes 3 and 4) indicate
that UL94 protein is localized to the nucleus of the UL94 cell
lines, as well. Analysis of the UL94 amino acid sequence indi-
cates a potential nuclear localization signal at residues 80 to 84
which could be involved in transport of the protein to the
nucleus (Fig. 7).
DISCUSSION
In this report, we identify a novel HCMV virion protein
which is conserved in all other human herpesviruses for which
sequence information in this region is available. The UL94
ORF was shown to encode a 36-kDa protein which was found
in productively infected cells only at late times of infection. In
the presence of viral DNA replication inhibitors, UL94-specific
message is not transcribed, indicating that UL94 is a true late
gene product. This establishes UL94 as one of the few true late
HCMV gene products documented to date. Since very little is
known about the regulation of true late genes during a pro-
ductive HCMV infection, an examination of the regulatory
mechanisms controlling UL94 expression should provide valu-
able information concerning the nature of HCMV late gene
expression. Such studies are under way in our laboratory.
Using Western blot analysis, we have demonstrated that
UL94 protein is associated with HCMV particles and, specif-
ically, with the capsid/tegument fraction of the virion. We had
originally anticipated an envelope association for UL94 pro-
tein, given its tendency to form what appear to be disulfide-
linked dimers in cell extracts from infected cells and when
FIG. 6. Western blot analysis of UL94 protein from 72-hpi-infected HEL and
95.15B cell nuclear and membrane/cytoplasmic fractions. The top panel shows
Western blot analysis of UL94 from 72-hpi-infected cell nuclear (N; lane 1) and
cytoplasmic/membrane (C/M; lane 2) fractions, as well as 94.15B cell cytoplas-
mic/membrane (lane 3) and nuclear (lane 4) fractions. The bottom panels show
the same extracts probed with antisera to cellular proteins Ras-specific GTPase-
activating protein (RasGAP) and p53.
FIG. 7. PILEUP analysis of UL94 protein sequence and its homologs from
varicella-zoster virus (44-Vzv), equine herpesvirus (Ul16-Hsveb), HSV (Ul16-
Hsv), Epstein-Barr virus (Bgl2-Ebv), herpesvirus saimiri (Ul16-Sam), human
herpesvirus 6 (Ul16_Hhvbu), and human cytomegalovirus (Ul94-Cmv). Con-
served features as well as other notable sequences are boxed and are discussed
fully in the text.
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purified as a histidine-tagged protein from UL94-expressing
cell lines. Viral envelope proteins have been previously shown
to form disulfide-linked complexes in cell extracts (14). The
localization of UL94 protein to the capsid/tegument fraction of
the virions as well as its localization to the nucleus of infected
and transfected cells, however, make the significance of these
disulfide-linked dimers unclear. While it is possible that virion
capsid or tegument proteins would be able to exist as disulfide-
linked dimers, it is highly unlikely that such an association
would exist in the nucleus of the infected cell since the reduc-
ing environment of the cell generally precludes formation of
such complexes. It is possible that the dimer form of UL94
seen in cell extracts simply represents a nonspecific aggrega-
tion of UL94 protein, since the protein is fairly abundant in
both infected and transfected cell extracts. Alternatively, it is
possible that the native conformation of UL94 protein pro-
duces an affinity of UL94 protein for itself and that these
associations are normally maintained by another mechanism.
In particular, the arrangement of the conserved cysteine resi-
dues in the C-terminal half of UL94 is somewhat reminiscent
of that seen in zinc-binding proteins. Other intracellular viral
proteins have been demonstrated to exist in an active form as
zinc-bridged dimers (26), and it should be possible to test
experimentally whether UL94 protein has an affinity for zinc
binding. In addition, immunohistology of infected cells as well
as electron microscopy of virus particles should provide useful
information with respect to UL94 protein localization once
reagents for such studies become available.
The exact function of the UL94 protein remains to be elu-
cidated. Reports from other laboratories have indicated that
the Epstein-Barr virus homolog of UL94 (BGLF2) is produced
during a lytic infection, but no virion-association was demon-
strated (11). Additionally, the HSV type 1 homolog of UL94
(UL16) has been shown to be dispensable for replication in
tissue culture, although as much as a log-fold drop in virus titer
can be seen in a cell-type-specific manner in the absence of
UL16 protein (4, 5). Assuming a conservation of function
among these proteins, this observation would seem to suggest
that UL94 is not an essential structural protein, despite its
presence in the mature virions. Rather, it may contribute to the
maintenance of a cellular environment conducive to viral rep-
lication, maturation, or egress that is nonessential in com-
pletely permissive cell types. Since UL94 is present in purified
virions, it is also likely to be introduced into the infected cell at
the earliest stages of viral infection. Within this context, it
could potentially play a role in regulation of viral and/or cel-
lular gene expression, as has been demonstrated for HCMV
tegument protein pp71 (23, 32), although what that role might
be is unclear. In this regard, it might prove interesting to
determine whether virion-associated UL94 protein localizes to
the nucleus following capsid uncoating.
Conserved features of UL94 and its homologs in other her-
pesviruses. It was previously reported that the UL94 coding
sequences were conserved in all other human herpesviruses (7,
8). To determine similarities in amino acid sequence, the pre-
dicted UL94 amino acid sequence was compared with those of
its homologs by using the PILEUP program (17). The results
indicated that the amino acid similarity is confined primarily to
the C-terminal halves of the proteins (Fig. 7). The UL94 pro-
tein was most similar to the UL16 protein of betaherpesvirus
human herpesvirus 6, while it was least similar to ORF44 of
varicella-zoster virus and UL16 of equine herpesvirus. Consis-
tent with the overall similarity among the herpesviruses, Ep-
stein-Barr virus, herpesvirus saimiri, and HSV occupied middle
positions with respect to percent homology of the UL94-like
proteins. A highly conserved three-residue sequence encom-
passing UL94 amino acids 175 to 177 (GAW) demarcates the
N-terminal boundary of the highly conserved region (boxed in
Fig. 7). Within this region there are also seven conserved
cysteine residues as well as two conserved histidine residues
(boxed in Fig. 7). The position of these residues is reminiscent
of that seen in zinc finger or zinc ring proteins, suggesting a
possible zinc and/or nucleic acid binding function for UL94. In
addition, the UL16 proteins of equine herpesvirus and HSV
type 1 as well as ORF44 of varicella-zoster virus contain a 5- to
10-residue C-terminal extension which is serine-threonine rich,
suggesting a possible region of phosphorylation in these pro-
teins. This region is not present in the other UL94 homologs;
however, a putative phosphorylation site of sequence aliphatic-
S-R is found at UL94 residues 311 to 313 and is 100% con-
served. The putative UL94 nuclear localization signal at amino
acids 80 to 84 (RRRRR) is also highlighted in Fig. 7. The exact
significance of this sequence is unclear since it is not well
conserved in the other UL94 homologs. It was previously re-
ported (11) that the Epstein-Barr virus BGLF2 protein con-
tained a putative nuclear localization signal at residues 65 to 69
(KPKKK). As with the putative UL94 nuclear localization sig-
nal, however, this sequence is not well conserved. Since both of
these sequences are within the less conserved region of these
proteins, it is possible that different mechanisms have evolved
for signaling nuclear localization of these proteins. Additional
characterization of UL94 and its homologs, however, is needed
to support this conclusion.
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